MANILA (Reuters) - The Philippines has approved a clinical trial for the COVID-19 vaccine of Johnson & Johnson’s unit Janssen, the head of its Food and Drug Administration (FDA) said on Tuesday.
The trials could begin in the next few weeks, FDA head Rolando Enrique Domingo told a media briefing.
The FDA is still evaluating the late-stage trial applications of Sinovac and Clover, Domingo said.
Reporting by Karen Lema; Editing by Martin Petty
Our Standards: The Thomson Reuters Trust Principles.